Harvard Women's Health Watch

Research we're watching: Experts add second drug to breast cancer prevention regimen

New guidelines advise postmenopausal women at increased risk for estrogen receptor-positive breast cancer to talk to their doctor about taking exemestane (Aromasin) as part of a preventive strategy.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In